rnl-bio-filed-ind-with-the-us-fda-to-begin-clinical-trials-with-rnl-jointstem

RNL BIO files IND for stem cell product with FDA

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: RNL BIO, Korea-based stem cell biotechnology company, has filed an Investigational New Drug application (IND) with the US FDA to begin clinical trials... Read more

selventa-s-systems-diagnostics-sysdx-multi-omic-analytics-platform-and-seegene-s-toce-and-dpo-multiplex-pcr-technology-combine-to-form-modx

Selventa, Seegene to accelerate personalized medicine

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Seoul-based Seegene and Selventa entered into a strategic collaboration to develop novel molecular diagnostics including autoimmune, cancer and infectious... Read more

seegene-gives-food-safety-tech-license-of-dpo-and-toce-technologies-to-biomerieux

Seegene gives food safety tech license to bioMérieux

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Seegene, a leading developer of multiplexed molecular technologies and diagnostic tests, has given bioMérieux license to the company's DPO and TOCE technologies... Read more

herapharm-will-be-distributing-bioelectronics-actipatch-musculoskeletal-pain-relief-recoveryrx-and-allay-menstrual-pain-products-in-korea

BioElectronics enters Korean pain relief market

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: BioElectronics, the maker of unique pain relief, inexpensive, patented, consumer medical devices, begun product distribution of its ActiPatch Musculoskeletal... Read more

sk-chemicals-gets-exclusive-rights-from-theravida-to-develop-and-commercialize-thvd-201-and-thvd-202-in-south-korea-for-the-treatment-of-overactive-bladder-oab-and-urge-urinary-incontinence-uui

SK gets rights to sell TheraVida urinary drugs

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: TheraVida and SK Chemicals announced the execution of a license agreement for two of TheraVida's proprietary combination drug product candidates, THVD-201... Read more

korea-arizona-trauma-summit-is-being-held-from-april-1-3-2013-in-arizona-us

Korea-Arizona trauma summit is underway

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: South Korea is trying to establish a national trauma system and is going to make several significant devlopments towards towards estabishing the same... Read more

good-news-for-cystic-acne-patients-dr

Korean, Chinese firms sign depression drug deal

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: South Korean-based SK Biopharmaceuticals entered into a collaboration agreement with PKU International HealthCare, China, and Shanghai Medicilon, China,... Read more

agilent-technologies-and-chungnam-national-university-south-korea-to-further-research-by-supporting-university-industry-training-programs

Agilent, Korean Univ study sugars to combat cancer

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Agilent Technologies and Korea's Chungnam National University have taken initiatives to further research in glycomics, which is the study of complex sugars,... Read more

dr-daehee-kang-chairman-board-of-directors-korean-association-of-medical-colleges-and-dean-seoul-national-university-college-of-medicine-south-korea

Daehee Kang: Healthcare challenges depends on a nation’s...

  • Korea
  • |
  • Influencers
  • |
  • By Piyusha Chatterjee
  • |
  • 0 Comment

Dr Daehee Kang, chairman, board of directors, Korean Association of Medical Colleges, and dean, Seoul National University College of Medicine, South Korea, is an... Read more

Previous 1 3 4 5 6 7

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X